Market research
VRAY ViewRay Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- 0.0%
- Beta
- 0.7
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Healthcare Equipment & Supplies
- ISIN
- US92672L1070
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- 0.0%
- Beta
- 0.7
About
About ViewRay Inc
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the VRAY discussion.
5 years, 4 months ago
ViewRay, Inc is currently in a long term uptrend where the price is trading 43.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.4.
ViewRay, Inc's total revenue rose by 12.1% to $18M since the same quarter in the previous year.
Its net income has increased by 25.9% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 146.5% to $-8M since the same quarter in the previous year.
Based on the above factors, ViewRay, Inc gets an overall score of 4/5.